Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #2,291 to #2,340.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research → Special:Badtitle/NS100:Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research
  2. Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation → Special:Badtitle/NS100:Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation
  3. Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes → Special:Badtitle/NS100:Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes
  4. CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents → Special:Badtitle/NS100:CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents
  5. Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction → Special:Badtitle/NS100:Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction
  6. Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease → Special:Badtitle/NS100:Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease
  7. Coronary heart disease mortality in young women makes the headline news → Special:Badtitle/NS100:Coronary heart disease mortality in young women makes the headline news
  8. Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study → Special:Badtitle/NS100:Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study
  9. Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction → Special:Badtitle/NS100:Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction
  10. Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability → Special:Badtitle/NS100:Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability
  11. Data from ADHERE: BNP and Troponin are independent predictors of in-hospital mortality in patients with decompensated heart failure → Special:Badtitle/NS100:Data from ADHERE: BNP and Troponin are independent predictors of in-hospital mortality in patients with decompensated heart failure
  12. Defribillators: Systematic Review of ICDs for Adults with LV Systolic Dysfunction → Special:Badtitle/NS100:Defribillators: Systematic Review of ICDs for Adults with LV Systolic Dysfunction
  13. Diabetes Care Makes an "ADVANCE" with Better Blood Pressure Control → Special:Badtitle/NS100:Diabetes Care Makes an "ADVANCE" with Better Blood Pressure Control
  14. Diagnosing Heart Failure in the Emergency Department → Special:Badtitle/NS100:Diagnosing Heart Failure in the Emergency Department
  15. Door-to-Ballon Time less than 90 Minutes is Achievable and Sustainable: the Geisinger experience. August 12, 2007 → Special:Badtitle/NS100:Door-to-Ballon Time less than 90 Minutes is Achievable and Sustainable: the Geisinger experience. August 12, 2007
  16. Dronedarone (Multaq®) a Promising New Drug for the Management of Patients with Atrial Fibrillation or Flutter → Special:Badtitle/NS100:Dronedarone (Multaq®) a Promising New Drug for the Management of Patients with Atrial Fibrillation or Flutter
  17. Drug-Eluting Stents: Meta-analysis Demonstrates Superior Clinical Performance of Sirolimus-eluting Stents (SES) Over Bare-metal Stents (BMS) and Paclitaxel-eluting Stents (PES) → Special:Badtitle/NS100:Drug-Eluting Stents: Meta-analysis Demonstrates Superior Clinical Performance of Sirolimus-eluting Stents (SES) Over Bare-metal Stents (BMS) and Paclitaxel-eluting Stents (PES)
  18. Drug Eluting Stents Continue to Demonstrate Superiority over Bare Metal Stents in Reducing the Need for Repeat Revascularization → Special:Badtitle/NS100:Drug Eluting Stents Continue to Demonstrate Superiority over Bare Metal Stents in Reducing the Need for Repeat Revascularization
  19. Drug Eluting Stents are Associated with Reduced Mortality Compared with Bare Metal Stents → Special:Badtitle/NS100:Drug Eluting Stents are Associated with Reduced Mortality Compared with Bare Metal Stents
  20. Drug eluting stents: GRACE Analysis Shows Five Times Higher Mortality Rate Between Six Months and Two Years Among Patients Receivng DES → Special:Badtitle/NS100:Drug eluting stents: GRACE Analysis Shows Five Times Higher Mortality Rate Between Six Months and Two Years Among Patients Receivng DES
  21. Drug eluting stents are associated with reduced mortality in patients with myocardial infarction at two years → Special:Badtitle/NS100:Drug eluting stents are associated with reduced mortality in patients with myocardial infarction at two years
  22. Dual therapy better than monotherapy to treat hypertension in the ACCOMPLISH trial → Special:Badtitle/NS100:Dual therapy better than monotherapy to treat hypertension in the ACCOMPLISH trial
  23. Duke Research Teams Provide Insight into Small Vessels, Stored Blood, and Nitric Oxide → Special:Badtitle/NS100:Duke Research Teams Provide Insight into Small Vessels, Stored Blood, and Nitric Oxide
  24. Early Transfer of AMI Patients for PCI improves cardiovascular outcomes in the TRANSFER-AMI study → Special:Badtitle/NS100:Early Transfer of AMI Patients for PCI improves cardiovascular outcomes in the TRANSFER-AMI study
  25. Elevated Plasma Fibrinogen Levels among Diabetics and Increased BMI are Associated with Reduced Platelet Inhibition with Clopidogrel → Special:Badtitle/NS100:Elevated Plasma Fibrinogen Levels among Diabetics and Increased BMI are Associated with Reduced Platelet Inhibition with Clopidogrel
  26. Elevated microalbuminuria within the “normal-range” predicts mortality in patients with stable angina → Special:Badtitle/NS100:Elevated microalbuminuria within the “normal-range” predicts mortality in patients with stable angina
  27. Emergency Medical Services Remain Underutilized in STEMI Patients → Special:Badtitle/NS100:Emergency Medical Services Remain Underutilized in STEMI Patients
  28. Eptifibatide: Result of EVA-AMI Trial Released → Special:Badtitle/NS100:Eptifibatide: Result of EVA-AMI Trial Released
  29. Eptifibatide: Results of BRIEF-PCI Trial Released → Special:Badtitle/NS100:Eptifibatide: Results of BRIEF-PCI Trial Released
  30. Erectile dysfunction is associated with adverse cardiovascular events among diabetic patients → Special:Badtitle/NS100:Erectile dysfunction is associated with adverse cardiovascular events among diabetic patients
  31. Even Crossing State Lines Improves Time to Treatment for STEMI : Mayo Clinic experience → Special:Badtitle/NS100:Even Crossing State Lines Improves Time to Treatment for STEMI : Mayo Clinic experience
  32. Excel biodegradable stents are safe and effective: Results from the CREATE trial → Special:Badtitle/NS100:Excel biodegradable stents are safe and effective: Results from the CREATE trial
  33. ExoSeal® Vascular Closure Device is safe and effective → Special:Badtitle/NS100:ExoSeal® Vascular Closure Device is safe and effective
  34. Expression of programmed death ligand-1 in donor hearts regulates chronic allograft rejection → Special:Badtitle/NS100:Expression of programmed death ligand-1 in donor hearts regulates chronic allograft rejection
  35. Extended Use of Clopidogrel is Associated with Reduction in Death or Death and Non-fatal Myocardial Infarction among Diabetics following PCI → Special:Badtitle/NS100:Extended Use of Clopidogrel is Associated with Reduction in Death or Death and Non-fatal Myocardial Infarction among Diabetics following PCI
  36. Ezetimibe and Simvastatin Combination in the SEAS Trial does Reduce Coronary Artery Events but Not the Progression of Aortic Stenosis → Special:Badtitle/NS100:Ezetimibe and Simvastatin Combination in the SEAS Trial does Reduce Coronary Artery Events but Not the Progression of Aortic Stenosis
  37. F.I.R.E. Study Misses Primary Endpoint → Special:Badtitle/NS100:F.I.R.E. Study Misses Primary Endpoint
  38. FDA Advisors Under Review for the Potential of Financial Conflict. August 8, 2007 → Special:Badtitle/NS100:FDA Advisors Under Review for the Potential of Financial Conflict
  39. FDA Panel Recommends Approval of New DES → Special:Badtitle/NS100:FDA Panel Recommends Approval of New DES
  40. FDA Requires Stronger Heart Failure Warning for Avandia and Actos → Special:Badtitle/NS100:FDA Requires Stronger Heart Failure Warning for Avandia and Actos
  41. FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study → Special:Badtitle/NS100:FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study
  42. Facilitated PCI: No Benefit in FINESSE → Special:Badtitle/NS100:Facilitated PCI: No Benefit in FINESSE
  43. Feedback regulation of catecholamines levels through an enzyme called renalase → Special:Badtitle/NS100:Feedback regulation of catecholamines levels through an enzyme called renalase
  44. Fibrinolysis Followed by PCI Yielded Similar 1-Year Survival Rates to Primary PCI for STEMI in the French Registry → Special:Badtitle/NS100:Fibrinolysis Followed by PCI Yielded Similar 1-Year Survival Rates to Primary PCI for STEMI in the French Registry
  45. Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial → Special:Badtitle/NS100:Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial
  46. Function of an obesity-associated gene defined → Special:Badtitle/NS100:Function of an obesity-associated gene defined
  47. IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes → Special:Badtitle/NS100:IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes
  48. New data on possible pro-thrombotic effects of pioglitazone → Special:Badtitle/NS100:New data on possible pro-thrombotic effects of pioglitazone
  49. Special:Badtitle/NS100:No Connection Between Vaccines & Autism, Original Data Faked in Lancet → Special:Badtitle/NS100:No Connection Between Vaccines & Autism, Original Data Faked in ''Lancet''
  50. No cardiovascular risk associated with coffee consumption after MI → Special:Badtitle/NS100:No cardiovascular risk associated with coffee consumption after MI

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"